Jasmin Kaivola Awarded the Elias Tillandz Prize

The Elias Tillandz Prize is awarded annually for the best research article by researchers from BioCity Turku, and this year, the prize was shared by two research articles. Before joining the chemistry team at Laine IP, Jasmin conducted research in the research group led by Johanna Ivaska.

The award-winning research demonstrates how the removal of the SHANK3 protein causes an overdose in cellular communication regulating growth and division, leading to the death of KRAS-mutated cancer cells. KRAS mutations account for over 20% of all cancer types and are notoriously difficult cancers to treat. The research utilizes, among other things, nanobodies that can be used as drugs.

Heräsikö kysyttävää? Laine IP:n kemian tiimin asiantuntijat auttavat sinua mielellään mm. lääkkeisiin, terapeuttisiin ja diagnostisiin liittyvissä IPR-asioissa.

Tutustu Jasminin artikkeliin täältä

Lue lisää Elias Tillandz -palkinnosta täältä